|
RNASEH2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.744800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.830400E-02 |
| Normal-vs-Stage2 |
5.674100E-02 |
| Normal-vs-Stage3 |
3.249800E-04 |
| Normal-vs-Stage4 |
4.216900E-04 |
| Stage1-vs-Stage2 |
4.144000E-01 |
| Stage1-vs-Stage3 |
2.292200E-02 |
| Stage1-vs-Stage4 |
2.132200E-02 |
| Stage2-vs-Stage3 |
4.535600E-01 |
| Stage2-vs-Stage4 |
4.856800E-01 |
| Stage3-vs-Stage4 |
9.963600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.181000E-03 |
| Normal-vs-AfricanAmerican |
2.452000E-02 |
| Normal-vs-Asian |
1.165910E-02 |
| Caucasian-vs-AfricanAmerican |
5.134000E-01 |
| Caucasian-vs-Asian |
6.125400E-01 |
| AfricanAmerican-vs-Asian |
7.923000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.678000E-03 |
| Normal-vs-Female |
8.082400E-03 |
| Male-vs-Female |
4.532000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.604200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.379100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.018000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.515430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.790040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.474000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.513960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.987400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.988000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.154800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.896000E-01 |
| Classical-VS-Follicular |
2.205000E-01 |
| Classical-VS-Other |
9.136200E-01 |
| Classical-VS-Normal |
4.000700E-03 |
| Tall-VS-Follicular |
1.070390E-01 |
| Tall-VS-Other |
7.795600E-01 |
| Tall-VS-Normal |
5.760900E-03 |
| Follicular-VS-Other |
6.397600E-01 |
| Follicular-VS-Normal |
3.186600E-01 |
| Other-VS-Normal |
1.836190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.638210E-02 |
| Normal-vs-N1 |
9.600700E-04 |
| N0-vs-N1 |
1.305840E-01 |
|
|
